Oxygenta Pharmaceutical Ltd.

Name: Oxygenta Pharmaceutical Ltd. Share Price Today, Stock Analysis
Brand: Oxygenta Pharmaceutical Ltd.

Stock Card

BSE: 524636

₹58.00

₹-1.48 (-2.49%)

As on 28-Aug-2026 11:03IST

Market cap

₹220 Cr

Revenue (TTM)

₹135 Cr

P/E Ratio

P/B Ratio

-4.9

Div. Yield

0 %

Oxygenta Pharma Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 57.95 High: 59.34

52 Week Range

Low: 43.00 High: 78.89

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

₹-14 Cr
ROE

0 %
ROCE

-33.5 %
Industry P/E

39.76
EV/EBITDA

-41.7
Debt to Equity

-2.6
Book Value

₹-12.1
EPS

₹-3.7
Face value

10
Shares outstanding

36,983,500

10 Years Aggregate

CFO

₹-51.49 Cr

EBITDA

₹-55.37 Cr

Net Profit

₹-59.98 Cr

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Oxygenta Pharma	4.0	11.3	10.1	-24.9	20.1	10.7	--
BSE Healthcare	18.6	2.7	8.5	16.9	23.1	14.8	12.4

As on 28-Aug-2026

Company	2025	2024	2023	2022
Oxygenta Pharma	-34.9	173.3	9.9	2.5
BSE Small Cap	-6.6	29.0	47.5	-1.8
BSE Healthcare	-3.3	43.1	37.0	-12.1

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price (₹)	Market Cap (₹ Cr)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
Oxygenta Pharma	58.0	220.0	134.8	-13.6	-7.5	--	--	-4.9
Acutaas Chemicals	3,277.8	27,284.0	1,461.8	387.4	34.5	25.2	70.6	15.8
Alembic Pharma	814.9	16,187.0	7,784.0	688.5	10.6	14	23.3	2.8
Cohance Lifesciences	450.2	17,368.0	2,141.5	58.5	5.8	3.3	163.5	4.5
Granules India	836.3	20,630.3	5,632.3	662.4	17.2	14.3	31.1	4.2
Onesource Specialty Pharma	1,527.9	17,399.9	1,543.3	-48.6	3.6	-0.6	--	3.0
Piramal Pharma	219.4	28,610.7	9,205.3	-371.8	1.7	-3.8	--	3.6
Rubicon Research	1,837.2	30,485.2	1,935.8	288.2	20.6	29.8	105.8	22.7
Syngene Intl	410.3	16,709.9	3,600.2	221.0	9.7	5.6	75.6	3.5
Wockhardt	2,029.3	31,863.1	3,564.0	414.0	15.3	8.4	77.9	6.3

Shareholding Pattern

View Details

News & Analysis

All News

No Review & Analysis are available.

About Oxygenta Pharma

S.S. Organics Limited manufactures and sells anti ulcerative and anti-bacterial drugs in India. It is also involved in contract manufacturing work, including cirprofloxacin HCL from Q-acid and cloxacillim sodium. The company was incorporated in 1990... and is based in Hyderabad, India. Read more

Incorporated

1990
Chairman

--
Managing Director

--
Headquarters

Sangareddy, Telangana
Website

www.oxygentapharma.com

Looking for more details about Oxygenta Pharmaceutical Ltd.’s IPO? Explore our IPO Details page.

FAQs for Oxygenta Pharma

What is the current share price of Oxygenta Pharmaceutical Ltd Today?

The share price of Oxygenta Pharmaceutical Ltd is ₹58.00 (BSE) as of 28-Aug-2026 11:03 IST. Oxygenta Pharmaceutical Ltd has given a return of 20.05% in the last 3 years.

What is the current PB & PE ratio of Oxygenta Pharmaceutical Ltd?

Since, TTM earnings of Oxygenta Pharmaceutical Ltd is negative, P/E ratio is not available.
The P/B ratio of Oxygenta Pharmaceutical Ltd is -4.91 times as on 27-Aug-2026, a 217 discount to its peers’ median range of 4.21 times.

PE & PB ratio at the end of financial year.

Year	P/E Ratio	P/B Ratio
2026	0.00	-4.19
2025	0.00	-11.48
2024	0.00	-4.69
2023	0.00	-1.13
2022	0.00	-0.99

What is the 52 Week High and Low of Oxygenta Pharmaceutical Ltd?

The 52-week high and low of Oxygenta Pharmaceutical Ltd are Rs 78.89 and Rs 43.00 as of 28-Aug-2026.

What is the market cap of Oxygenta Pharmaceutical Ltd?

Oxygenta Pharmaceutical Ltd has a market capitalisation of ₹ 220 Cr as on 27-Aug-2026. As per SEBI classification, it is a Small Cap company.

Should I invest in Oxygenta Pharmaceutical Ltd?

Before investing in Oxygenta Pharmaceutical Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.

Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.